SNWV
SANUWAVE Health, Inc.

226
Mkt Cap
$219.81M
Volume
10,911.00
52W High
$46.59
52W Low
$23.55
PE Ratio
-15.20
SNWV Fundamentals
Price
$25.91
Prev Close
$25.63
Open
$25.58
50D MA
$29.60
Beta
0.96
Avg. Volume
54,906.50
EPS (Annual)
-$7.03
P/B
-74.99
Rev/Employee
$709,434.78
Loading...
Loading...
News
all
press releases
SANUWAVE Health (OTCMKTS:SNWV) Share Price Passes Below Fifty Day Moving Average - Time to Sell?
SANUWAVE Health (OTCMKTS:SNWV) Stock Price Passes Below 50-Day Moving Average - Here's What Happened...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
SANUWAVE Health (OTCMKTS:SNWV) Share Price Crosses Below Fifty Day Moving Average - Should You Sell?
SANUWAVE Health (OTCMKTS:SNWV) Share Price Passes Below Fifty Day Moving Average - Here's Why...
MarketBeat·4d ago
News Placeholder
Sanuwave Health (NASDAQ:SNWV) Stock Price Down 1% - Should You Sell?
Sanuwave Health (NASDAQ:SNWV) Trading Down 1% - Here's What Happened...
MarketBeat·12d ago
News Placeholder
SANUWAVE Health (OTCMKTS:SNWV) Shares Down 1% - Here's Why
SANUWAVE Health (OTCMKTS:SNWV) Trading Down 1% - Here's Why...
MarketBeat·13d ago
News Placeholder
Stonebridge Wealth Management LLC Invests $1.70 Million in Sanuwave Health Inc. $SNWV
Stonebridge Wealth Management LLC acquired a new stake in Sanuwave Health Inc. (NASDAQ:SNWV - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·2mo ago
News Placeholder
SANUWAVE Health (OTCMKTS:SNWV) Trading Up 1.4% - Still a Buy?
SANUWAVE Health (OTCMKTS:SNWV) Trading Up 1.4% - Time to Buy...
MarketBeat·2mo ago
News Placeholder
Sanuwave Health (NASDAQ:SNWV) Upgraded by Wall Street Zen to "Buy" Rating
Wall Street Zen upgraded Sanuwave Health from a "hold" rating to a "buy" rating in a research note on Saturday...
MarketBeat·3mo ago
News Placeholder
Sanuwave Health Inc. (SNWV) Beats Q3 Earnings and Revenue Estimates
Sanuwave Health (SNWV) delivered earnings and revenue surprises of +43.75% and +0.18%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Insulet (PODD) Q3 Earnings and Revenues Beat Estimates
Insulet (PODD) delivered earnings and revenue surprises of +9.73% and +4.42%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
MariMed Inc. (MRMD) Reports Q3 Loss, Misses Revenue Estimates
MariMed Inc. (MRMD) delivered earnings and revenue surprises of 0.00% and -3.29%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
<
1
2
...
>

Latest SNWV News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.